Skip to main content
Erschienen in: Journal of General Internal Medicine 9/2021

06.01.2021 | Original Research

How Well Does the Surprise Question Predict 1-year Mortality for Patients Admitted with COPD?

verfasst von: Dana Tripp, BA, Jaclyn Janis, MPH, BSN, RN, Benjamin Jarrett, MD, MPH, F. Lee Lucas, PhD, Tania D. Strout, PhD, RN, MS, Paul K. J. Han, MD MA MPH, Isabella Stumpf, DO, Rebecca N. Hutchinson, MD, MPH

Erschienen in: Journal of General Internal Medicine | Ausgabe 9/2021

Einloggen, um Zugang zu erhalten

Abstract

Background

Patients with chronic obstructive pulmonary disease (COPD) often receive burdensome care at end-of-life (EOL) and infrequently complete advance care planning (ACP). The surprise question (SQ) is a prognostic tool that may facilitate ACP.

Objective

To assess how well the SQ predicts mortality and prompts ACP for COPD patients.

Design

Retrospective cohort study.

Subjects

Patients admitted to the hospital for an acute exacerbation of COPD between July 2015 and September 2018.

Main Measures

Emergency department (ED) and inpatient clinicians answered, “Would you be surprised if this patient died in the next 30 days (ED)/one year (inpatient)?” The primary outcome measure was the accuracy of the SQ in predicting 30-day and 1-year mortality. The secondary outcome was the correlation between SQ and ACP (palliative care consultation, documented goals-of-care conversation, change in code status, or completion of ACP document).

Key Results

The 30-day SQ had a high specificity but low sensitivity for predicting 30-day mortality: sensitivity 12%, specificity 95%, PPV 11%, and NPV 96%. The 1-year SQ demonstrated better accuracy for predicting 1-year mortality: sensitivity 47%, specificity 75%, PPV 35%, and NPV 83%. After multivariable adjustment for age, sex, and prior 6-month admissions, 1-year SQ+ responses were associated with greater odds of 1-year mortality (OR 2.38, 95% CI 1.39–4.08) versus SQ-. One-year SQ+ patients were more likely to have a goals-of-care conversation (25% vs. 11%, p < 0.01) and complete an advance directive or POLST (46% vs. 23%, p < 0.01). After multivariable adjustment, SQ+ responses to the 1-year SQ were associated with greater odds of ACP receipt (OR 2.67, 95% CI 1.64–4.36).

Conclusions

The 1-year surprise question may be an effective component of prognostication and advance care planning for COPD patients in the inpatient setting.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
2.
Zurück zum Zitat Murray CJL, Lopez AD. Alternative projections of mortality and disability by cause 1990–2020: Global Burden of Disease Study. The Lancet. 1997;349(9064):1498-1504.CrossRef Murray CJL, Lopez AD. Alternative projections of mortality and disability by cause 1990–2020: Global Burden of Disease Study. The Lancet. 1997;349(9064):1498-1504.CrossRef
3.
Zurück zum Zitat Elkington H, White P, Addington-Hall J, Higgs R, Pettinari C. The last year of life of COPD: a qualitative study of symptoms and services. Respiratory Medicine. 2004;98(5):439-445.PubMedCrossRef Elkington H, White P, Addington-Hall J, Higgs R, Pettinari C. The last year of life of COPD: a qualitative study of symptoms and services. Respiratory Medicine. 2004;98(5):439-445.PubMedCrossRef
4.
Zurück zum Zitat Maurer J, Rebbapragada V, Borson S, et al. Anxiety and Depression in COPD: Current Understanding, Unanswered Questions, and Research Needs. Chest. 2008;134(4, Supplement):43S-56S.PubMedCrossRef Maurer J, Rebbapragada V, Borson S, et al. Anxiety and Depression in COPD: Current Understanding, Unanswered Questions, and Research Needs. Chest. 2008;134(4, Supplement):43S-56S.PubMedCrossRef
5.
Zurück zum Zitat Solano JP, Gomes B, Higginson IJ. A Comparison of Symptom Prevalence in Far Advanced Cancer, AIDS, Heart Disease, Chronic Obstructive Pulmonary Disease and Renal Disease. Journal of Pain and Symptom Management. 2006;31(1):58-69.PubMedCrossRef Solano JP, Gomes B, Higginson IJ. A Comparison of Symptom Prevalence in Far Advanced Cancer, AIDS, Heart Disease, Chronic Obstructive Pulmonary Disease and Renal Disease. Journal of Pain and Symptom Management. 2006;31(1):58-69.PubMedCrossRef
6.
Zurück zum Zitat Claessens MT, Lynn J, Zhong Z, et al. Dying with lung cancer or chronic obstructive pulmonary disease: insights from SUPPORT. J Am Geriatr Soc. 2000;48(S1):S146-S153.PubMedCrossRef Claessens MT, Lynn J, Zhong Z, et al. Dying with lung cancer or chronic obstructive pulmonary disease: insights from SUPPORT. J Am Geriatr Soc. 2000;48(S1):S146-S153.PubMedCrossRef
7.
Zurück zum Zitat De Schreye R, Smets T, Deliens L, Annemans L, Gielen B, Cohen J. Appropriateness of End-of-Life Care in People Dying From COPD. Applying Quality Indicators on Linked Administrative Databases. Journal of Pain and Symptom Management. 2018;56(4):541-550.e546.PubMedCrossRef De Schreye R, Smets T, Deliens L, Annemans L, Gielen B, Cohen J. Appropriateness of End-of-Life Care in People Dying From COPD. Applying Quality Indicators on Linked Administrative Databases. Journal of Pain and Symptom Management. 2018;56(4):541-550.e546.PubMedCrossRef
8.
Zurück zum Zitat Gore JM, Brophy CJ, Greenstone MA. How well do we care for patients with end stage chronic obstructive pulmonary disease (COPD)? A comparison of palliative care and quality of life in COPD and lung cancer. Thorax. 2000;55(12):1000-1006.PubMedPubMedCentralCrossRef Gore JM, Brophy CJ, Greenstone MA. How well do we care for patients with end stage chronic obstructive pulmonary disease (COPD)? A comparison of palliative care and quality of life in COPD and lung cancer. Thorax. 2000;55(12):1000-1006.PubMedPubMedCentralCrossRef
9.
Zurück zum Zitat Reinke LF, Slatore CG, Uman J, et al. Patient–clinician communication about end-of-life care topics: Is anyone talking to patients with chronic obstructive pulmonary disease? Journal of palliative medicine. 2011;14(8):923-928.PubMedCrossRef Reinke LF, Slatore CG, Uman J, et al. Patient–clinician communication about end-of-life care topics: Is anyone talking to patients with chronic obstructive pulmonary disease? Journal of palliative medicine. 2011;14(8):923-928.PubMedCrossRef
10.
Zurück zum Zitat Au DH, Udris EM, Engelberg RA, et al. A randomized trial to improve communication about end-of-life care among patients with COPD. Chest. 2012;141(3):726-735.PubMedCrossRef Au DH, Udris EM, Engelberg RA, et al. A randomized trial to improve communication about end-of-life care among patients with COPD. Chest. 2012;141(3):726-735.PubMedCrossRef
11.
Zurück zum Zitat Janssen DJ, Spruit MA, Schols JM, Wouters EF. A call for high-quality advance care planning in outpatients with severe COPD or chronic heart failure. Chest. 2011;139(5):1081-1088.PubMedCrossRef Janssen DJ, Spruit MA, Schols JM, Wouters EF. A call for high-quality advance care planning in outpatients with severe COPD or chronic heart failure. Chest. 2011;139(5):1081-1088.PubMedCrossRef
12.
Zurück zum Zitat Siouta N, Clement P, Aertgeerts B, Van Beek K, Menten J. Professionals’ perceptions and current practices of integrated palliative care in chronic heart failure and chronic obstructive pulmonary disease: a qualitative study in Belgium. BMC Palliat Care. 2018;17(1):103.PubMedPubMedCentralCrossRef Siouta N, Clement P, Aertgeerts B, Van Beek K, Menten J. Professionals’ perceptions and current practices of integrated palliative care in chronic heart failure and chronic obstructive pulmonary disease: a qualitative study in Belgium. BMC Palliat Care. 2018;17(1):103.PubMedPubMedCentralCrossRef
13.
Zurück zum Zitat Bloom CI, Slaich B, Morales DR, Smeeth L, Stone P, Quint JK. Low uptake of palliative care for COPD patients within primary care in the UK. European Respiratory Journal. 2018;51(2):1701879.CrossRef Bloom CI, Slaich B, Morales DR, Smeeth L, Stone P, Quint JK. Low uptake of palliative care for COPD patients within primary care in the UK. European Respiratory Journal. 2018;51(2):1701879.CrossRef
15.
Zurück zum Zitat Bertens LCM, Reitsma JB, Moons KGM, et al. Development and validation of a model to predict the risk of exacerbations in chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2013;8:493-499.PubMedPubMedCentralCrossRef Bertens LCM, Reitsma JB, Moons KGM, et al. Development and validation of a model to predict the risk of exacerbations in chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2013;8:493-499.PubMedPubMedCentralCrossRef
16.
Zurück zum Zitat Smith L-JE, Moore E, Ali I, Smeeth L, Stone P, Quint JK. Prognostic variables and scores identifying the end of life in COPD: a systematic review. Int J Chron Obstruct Pulmon Dis. 2017;12:2239-2256.PubMedPubMedCentralCrossRef Smith L-JE, Moore E, Ali I, Smeeth L, Stone P, Quint JK. Prognostic variables and scores identifying the end of life in COPD: a systematic review. Int J Chron Obstruct Pulmon Dis. 2017;12:2239-2256.PubMedPubMedCentralCrossRef
17.
Zurück zum Zitat Boeck L, Soriano JB, Brusse-Keizer M, et al. Prognostic assessment in COPD without lung function: the B-AE-D indices. European Respiratory Journal. 2016;47(6):1635-1644.CrossRef Boeck L, Soriano JB, Brusse-Keizer M, et al. Prognostic assessment in COPD without lung function: the B-AE-D indices. European Respiratory Journal. 2016;47(6):1635-1644.CrossRef
18.
Zurück zum Zitat Steer J, Gibson J, Bourke SC. The DECAF Score: predicting hospital mortality in exacerbations of chronic obstructive pulmonary disease. Thorax. 2012;67(11):970.PubMedCrossRef Steer J, Gibson J, Bourke SC. The DECAF Score: predicting hospital mortality in exacerbations of chronic obstructive pulmonary disease. Thorax. 2012;67(11):970.PubMedCrossRef
19.
Zurück zum Zitat Fawzy A, Anderson JA, Cowans NJ, et al. Association of platelet count with all-cause mortality and risk of cardiovascular and respiratory morbidity in stable COPD. Respiratory Research. 2019;20(1):86.PubMedPubMedCentralCrossRef Fawzy A, Anderson JA, Cowans NJ, et al. Association of platelet count with all-cause mortality and risk of cardiovascular and respiratory morbidity in stable COPD. Respiratory Research. 2019;20(1):86.PubMedPubMedCentralCrossRef
20.
Zurück zum Zitat Aaronson EL, George N, Ouchi K, et al. The Surprise Question Can Be Used to Identify Heart Failure Patients in the Emergency Department Who Would Benefit From Palliative Care. J Pain Symptom Manage. 2019;57(5):944-951.PubMedPubMedCentralCrossRef Aaronson EL, George N, Ouchi K, et al. The Surprise Question Can Be Used to Identify Heart Failure Patients in the Emergency Department Who Would Benefit From Palliative Care. J Pain Symptom Manage. 2019;57(5):944-951.PubMedPubMedCentralCrossRef
21.
Zurück zum Zitat Straw S, Byrom R, Gierula J, et al. Predicting one-year mortality in heart failure using the ‘Surprise Question’: a prospective pilot study. European Journal of Heart Failure. 2019;21(2):227-234.PubMed Straw S, Byrom R, Gierula J, et al. Predicting one-year mortality in heart failure using the ‘Surprise Question’: a prospective pilot study. European Journal of Heart Failure. 2019;21(2):227-234.PubMed
22.
Zurück zum Zitat Lakin JR, Robinson MG, Bernacki RE, et al. Estimating 1-Year Mortality for High-Risk Primary Care Patients Using the “Surprise” Question. JAMA Intern Med. 2016;176(12):1863-1865.PubMedPubMedCentralCrossRef Lakin JR, Robinson MG, Bernacki RE, et al. Estimating 1-Year Mortality for High-Risk Primary Care Patients Using the “Surprise” Question. JAMA Intern Med. 2016;176(12):1863-1865.PubMedPubMedCentralCrossRef
23.
Zurück zum Zitat Ouchi K, Strout T, Haydar S, et al. Association of Emergency Clinicians' Assessment of Mortality Risk With Actual 1-Month Mortality Among Older Adults Admitted to the Hospital. JAMA Network Open. 2019;2(9):e1911139-e1911139.PubMedPubMedCentralCrossRef Ouchi K, Strout T, Haydar S, et al. Association of Emergency Clinicians' Assessment of Mortality Risk With Actual 1-Month Mortality Among Older Adults Admitted to the Hospital. JAMA Network Open. 2019;2(9):e1911139-e1911139.PubMedPubMedCentralCrossRef
24.
Zurück zum Zitat Haydar SA, Strout TD, Bond AG, Han PKJ. Prognostic value of a modified surprise question designed for use in the emergency department setting. Clin Exp Emerg Med. 2019;6(1):70-76.PubMedPubMedCentralCrossRef Haydar SA, Strout TD, Bond AG, Han PKJ. Prognostic value of a modified surprise question designed for use in the emergency department setting. Clin Exp Emerg Med. 2019;6(1):70-76.PubMedPubMedCentralCrossRef
25.
Zurück zum Zitat Downar J, Goldman R, Pinto R, Englesakis M, Adhikari NK. The “surprise question” for predicting death in seriously ill patients: a systematic review and meta-analysis. Can Med Assoc J. 2017;189(13):E484-E493.CrossRef Downar J, Goldman R, Pinto R, Englesakis M, Adhikari NK. The “surprise question” for predicting death in seriously ill patients: a systematic review and meta-analysis. Can Med Assoc J. 2017;189(13):E484-E493.CrossRef
26.
Zurück zum Zitat Moss AH, Ganjoo J, Sharma S, et al. Utility of the “surprise” question to identify dialysis patients with high mortality. Clin J Am Soc Nephrol. 2008;3(5):1379-1384.PubMedPubMedCentralCrossRef Moss AH, Ganjoo J, Sharma S, et al. Utility of the “surprise” question to identify dialysis patients with high mortality. Clin J Am Soc Nephrol. 2008;3(5):1379-1384.PubMedPubMedCentralCrossRef
27.
Zurück zum Zitat Moss AH, Lunney JR, Culp S, et al. Prognostic significance of the "surprise" question in cancer patients. J Palliat Med. 2010;13(7):837-840.PubMedCrossRef Moss AH, Lunney JR, Culp S, et al. Prognostic significance of the "surprise" question in cancer patients. J Palliat Med. 2010;13(7):837-840.PubMedCrossRef
28.
Zurück zum Zitat Vick JB, Pertsch N, Hutchings M, et al. The utility of the surprise question in identifying patients most at risk of death. Journal of Clinical Oncology. 2015;33(29_suppl):8-8.CrossRef Vick JB, Pertsch N, Hutchings M, et al. The utility of the surprise question in identifying patients most at risk of death. Journal of Clinical Oncology. 2015;33(29_suppl):8-8.CrossRef
29.
Zurück zum Zitat Feyi K, Klinger S, Pharro G, et al. Predicting palliative care needs and mortality in end stage renal disease: use of an at-risk register. BMJ Support Palliat Care. 2015;5(1):19-25.PubMedCrossRef Feyi K, Klinger S, Pharro G, et al. Predicting palliative care needs and mortality in end stage renal disease: use of an at-risk register. BMJ Support Palliat Care. 2015;5(1):19-25.PubMedCrossRef
30.
Zurück zum Zitat Hamano J, Morita T, Inoue S, et al. Surprise questions for survival prediction in patients with advanced cancer: a multicenter prospective cohort study. Oncologist. 2015;20(7):839-844.PubMedPubMedCentralCrossRef Hamano J, Morita T, Inoue S, et al. Surprise questions for survival prediction in patients with advanced cancer: a multicenter prospective cohort study. Oncologist. 2015;20(7):839-844.PubMedPubMedCentralCrossRef
31.
Zurück zum Zitat Pang WF, Kwan BC, Chow KM, Leung CB, Li PK, Szeto CC. Predicting 12-month mortality for peritoneal dialysis patients using the "surprise" question. Perit Dial Int. 2013;33(1):60-66.PubMedPubMedCentralCrossRef Pang WF, Kwan BC, Chow KM, Leung CB, Li PK, Szeto CC. Predicting 12-month mortality for peritoneal dialysis patients using the "surprise" question. Perit Dial Int. 2013;33(1):60-66.PubMedPubMedCentralCrossRef
32.
Zurück zum Zitat Rhee J, Clayton JM. The ‘surprise’ question may improve the accuracy of GPs in identifying death in patients with advanced stage IV solid-cell cancer. Evid Based Med. 2015;20(2):71.PubMedCrossRef Rhee J, Clayton JM. The ‘surprise’ question may improve the accuracy of GPs in identifying death in patients with advanced stage IV solid-cell cancer. Evid Based Med. 2015;20(2):71.PubMedCrossRef
33.
Zurück zum Zitat Noppe D, Veen Hit, Mooren K. COPD patients in need of palliative care: Identification after hospitalization through the surprise question. Chronic Respiratory Disease. 2019;16:1479972318796219.PubMedCrossRef Noppe D, Veen Hit, Mooren K. COPD patients in need of palliative care: Identification after hospitalization through the surprise question. Chronic Respiratory Disease. 2019;16:1479972318796219.PubMedCrossRef
34.
Zurück zum Zitat South G, Reddington O, Hatfield L, Phillips A, Wall H. End of life in COPD: There may be no surprises! European Respiratory Journal. 2011;38(Suppl 55):p1241. South G, Reddington O, Hatfield L, Phillips A, Wall H. End of life in COPD: There may be no surprises! European Respiratory Journal. 2011;38(Suppl 55):p1241.
36.
Zurück zum Zitat Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42(2):377-381.CrossRefPubMed Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42(2):377-381.CrossRefPubMed
37.
Zurück zum Zitat Keating NL, Huskamp HA, Kouri E, et al. Factors contributing to geographic variation in end-of-life expenditures for cancer patients. Health Aff (Millwood). 2018;37(7):1136-1143.PubMedPubMedCentralCrossRef Keating NL, Huskamp HA, Kouri E, et al. Factors contributing to geographic variation in end-of-life expenditures for cancer patients. Health Aff (Millwood). 2018;37(7):1136-1143.PubMedPubMedCentralCrossRef
38.
Zurück zum Zitat Sudore RL, Lum HD, You JJ, et al. Defining advance care planning for adults: a consensus definition from a multidisciplinary Delphi panel. J Pain Symptom Manage. 2017;53(5):821-832.e821.PubMedPubMedCentralCrossRef Sudore RL, Lum HD, You JJ, et al. Defining advance care planning for adults: a consensus definition from a multidisciplinary Delphi panel. J Pain Symptom Manage. 2017;53(5):821-832.e821.PubMedPubMedCentralCrossRef
39.
Zurück zum Zitat Edmonds KP, Ajayi TA. Do We Know What We Mean? An Examination of the Use of the Phrase “Goals of Care” in the Literature. Journal of Palliative Medicine. 2019;22(12):1546-1552.PubMedCrossRef Edmonds KP, Ajayi TA. Do We Know What We Mean? An Examination of the Use of the Phrase “Goals of Care” in the Literature. Journal of Palliative Medicine. 2019;22(12):1546-1552.PubMedCrossRef
42.
Zurück zum Zitat White N, Kupeli N, Vickerstaff V, Stone P. How accurate is the 'Surprise Question' at identifying patients at the end of life? A systematic review and meta-analysis. BMC Med. 2017;15(1):139.PubMedPubMedCentralCrossRef White N, Kupeli N, Vickerstaff V, Stone P. How accurate is the 'Surprise Question' at identifying patients at the end of life? A systematic review and meta-analysis. BMC Med. 2017;15(1):139.PubMedPubMedCentralCrossRef
43.
Zurück zum Zitat Singh S, Rodriguez A, Lee D, Min S-J, Fischer S. Usefulness of the Surprise Question on an Inpatient Oncology Service. American Journal of Hospice and Palliative Medicine®. 2018;35(11):1421-1425.CrossRef Singh S, Rodriguez A, Lee D, Min S-J, Fischer S. Usefulness of the Surprise Question on an Inpatient Oncology Service. American Journal of Hospice and Palliative Medicine®. 2018;35(11):1421-1425.CrossRef
44.
Zurück zum Zitat Haydar SA, Almeder L, Michalakes L, Han PK, Strout TD. Using the Surprise Question To Identify Those with Unmet Palliative Care Needs in Emergency and Inpatient Settings: What Do Clinicians Think? J Palliat Med. 2017. Haydar SA, Almeder L, Michalakes L, Han PK, Strout TD. Using the Surprise Question To Identify Those with Unmet Palliative Care Needs in Emergency and Inpatient Settings: What Do Clinicians Think? J Palliat Med. 2017.
45.
Zurück zum Zitat Moss AH, Lunney JR, Culp S, et al. Prognostic Significance of the “Surprise” Question in Cancer Patients. Journal of Palliative Medicine. 2010;13(7):837-840.PubMedCrossRef Moss AH, Lunney JR, Culp S, et al. Prognostic Significance of the “Surprise” Question in Cancer Patients. Journal of Palliative Medicine. 2010;13(7):837-840.PubMedCrossRef
46.
Zurück zum Zitat Gerlach C, Goebel S, Weber S, Weber M, Sleeman KE. Space for intuition – the ‘Surprise’-Question in haemato-oncology: Qualitative analysis of experiences and perceptions of haemato-oncologists. Palliative Medicine. 2019;33(5):531-540.PubMedCrossRef Gerlach C, Goebel S, Weber S, Weber M, Sleeman KE. Space for intuition – the ‘Surprise’-Question in haemato-oncology: Qualitative analysis of experiences and perceptions of haemato-oncologists. Palliative Medicine. 2019;33(5):531-540.PubMedCrossRef
Metadaten
Titel
How Well Does the Surprise Question Predict 1-year Mortality for Patients Admitted with COPD?
verfasst von
Dana Tripp, BA
Jaclyn Janis, MPH, BSN, RN
Benjamin Jarrett, MD, MPH
F. Lee Lucas, PhD
Tania D. Strout, PhD, RN, MS
Paul K. J. Han, MD MA MPH
Isabella Stumpf, DO
Rebecca N. Hutchinson, MD, MPH
Publikationsdatum
06.01.2021
Verlag
Springer International Publishing
Erschienen in
Journal of General Internal Medicine / Ausgabe 9/2021
Print ISSN: 0884-8734
Elektronische ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-020-06512-8

Weitere Artikel der Ausgabe 9/2021

Journal of General Internal Medicine 9/2021 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Reizdarmsyndrom: Diäten wirksamer als Medikamente

29.04.2024 Reizdarmsyndrom Nachrichten

Bei Reizdarmsyndrom scheinen Diäten, wie etwa die FODMAP-arme oder die kohlenhydratreduzierte Ernährung, effektiver als eine medikamentöse Therapie zu sein. Das hat eine Studie aus Schweden ergeben, die die drei Therapieoptionen im direkten Vergleich analysierte.

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.